Skip to content

Study on post-dialysis fatigue in home hemodialysis patents

Study on post-dialysis fatigue in home hemodialysis patents - Study on post-dialysis fatigue in home hemodialysis patents

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000038170
Enrollment
50
Registered
2019-10-15
Start date
2019-10-15
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic kidney disease

Interventions

None listed

Sponsors

Fuke Home Medical Rehabilitation Care Center Medical division
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: The PDF scale is implemented for 30 home hemodialysis patients residing in Fujimino medical home that has received written consent.

Exclusion criteria

Exclusion criteria: Hemodialysis patients are excluded from this study when they discontinue dialysis, transition to peritoneal dialysis, combined with peritoneal dialysis, or receive kidney transplantation.

Design outcomes

Primary

MeasureTime frame
The primary end point of this study is to compare post-dialysis fatigue in home hemodialysis and outpatient maintenance dialysis patients, and to clarify the current status of post-dialysis fatigue and the factors affecting QOL. PDF scale is performed 3 times a month from the first time.

Secondary

MeasureTime frame
Physical functioning, recovery time, fatigue scale, self-rated health, fatigue symptoms before dialysis, basic patient information (age, sex, dialysis history, past history), nutritional evaluation (serum Evaluate albumin concentration), dialysis efficiency (Kt / V), and changes in systolic blood pressure before and after dialysis.

Countries

Japan

Contacts

Public ContactAkira Tsuji

Fuke Home Medical Rehabilitation Care Center Medical division

atsuji@fukekai.com049-293-8222

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026